Grigoriadis Dimitri E. 4
4 · NEUROCRINE BIOSCIENCES INC · Filed Jun 15, 2020
Insider Transaction Report
Form 4
Grigoriadis Dimitri E.
Vice President, Research
Transactions
- Exercise/Conversion
Common Stock
2020-06-11$32.99/sh+2,710$89,403→ 74,702 total - Exercise/Conversion
Common Stock
2020-06-11$43.24/sh+1,049$45,359→ 77,563 total - Exercise/Conversion
Incentive Stock Option
2020-06-11$35.99/sh−1,812$65,214→ 0 totalExercise: $35.99Exp: 2026-02-05→ Common Stock (1,812 underlying) - Exercise/Conversion
Incentive Stock Option
2020-06-11$32.99/sh−2,710$89,403→ 0 totalExercise: $32.99Exp: 2025-02-03→ Common Stock (2,710 underlying) - Exercise/Conversion
Common Stock
2020-06-11$35.99/sh+1,812$65,214→ 76,514 total - Exercise/Conversion
Incentive Stock Option
2020-06-11$43.24/sh−1,049$45,359→ 2,151 totalExercise: $43.24Exp: 2027-02-06→ Common Stock (1,049 underlying)
Footnotes (3)
- [F1]Option granted February 3, 2015 and vested monthly over four years.
- [F2]Option granted February 5, 2016 and vested monthly over four years.
- [F3]Option granted February 6, 2017 and vests monthly over four years.